通过反向抗毒学方法增强肉毒抗毒剂
Tassia Chiarelli1, Jackelinne Y Hayashi1, Nathalia da Costa Galizio2
1Departamento de Bioquímica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04023-901, Brazil.
Journal of proteome research
|January 22, 2025
概括
研究人员通过丰富毒素特异性抗体和减少血清蛋白来改善蛇毒药. 这种增强的抗毒素 (iBAv) 显示出更强的效力和减少了用于治疗Bothrops蛇咬伤的非特异性蛋白质.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗毒药对于治疗蛇毒非常重要,但由于非特异性抗体和血清蛋白质,可以引起不良反应.
- 目前的动物衍生抗毒剂虽然可以挽救生命,但含有杂质,需要改进以提高安全性和有效性.
研究的目的:
- 通过丰富毒素特异性抗体和消耗血清蛋白来开发一种改进的人类抗毒剂 (iBAv).
- 为了增强抗毒药对 * Bothrops jararaca * 毒的功效并降低抗毒药的免疫成分.
主要方法:
- 使用固定的 * Bothrops jararaca * 毒素来捕获特定的抗体.
- 蛋白质组分析以量化血清蛋白质耗尽 (白蛋白和其他).
- 表面等离子体共振 (SPR) 来评估毒素结合亲和力和*体内*研究来确定中位有效剂量 (ED50).
主要成果:
- 改进的抗毒药物 (iBAv) 与原始人体抗毒药物 (BAv) 相比,显示了87%的白蛋白和37-83%的其他血清蛋白减少.
- iBAv对毒毒素的亲和力高出2.9倍,ED50*in vivo*降低了2.8倍,这表明中和力显著增强.
- 净化过程成功丰富了中和抗体,同时去除了非特异性血清蛋白.
结论:
- 在抗毒中丰富特定抗体和耗尽血清蛋白减少了总蛋白质剂量,并增加了效力.
- 这种亲和性丰富的抗毒剂代表了提高对*Bothrops jararaca*中毒的疗效的重大进展.
- 为了大规模实施,需要进一步开发,但这种方法为下一代抗毒药提供了一个有希望的战略.
相关概念视频
Cross-reactivity
30.9K
Overview
30.9K
Antidotes
608
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
608
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


